Company
Laboratorios Richmond S.A.C.I.F.
Headquarters: Buenos Aires, Argentina
Employees: 400
CEO: Juan Manuel Artola
Market Cap
AR$144.95 Billion
ARS as of Jan. 1, 2025
US$140.6 Million
Laboratorios Richmond S.A.C.I.F. Categories
Argentina Healthcare Drug Manufacturers—Specialty & GenericArgentina Healthcare Argentina Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Laboratorios Richmond S.A.C.I.F., a pharmaceutical company, develops and manufactures pharmaceutical products. It provides antivirals for the treatment of HIV and HCV; oncology and oncohematology drugs; cardiometabolic drugs, including antihypertensive, cholesterol-lowering, and anti platelet drugs; and psychiatric drugs comprising analgesic, anti psychotic, anti depressive, anti dementia, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company sells its products in Latin America, Africa, Asia, and the Middle East. Laboratorios Richmond S.A.C.I.F. was founded in 1935 and is based in Buenos Aires, Argentina.
Stocks & Indices
Laboratorios Richmond S.A.C.I.F. has the following listings and related stock indices.
Stock: BCBA: RICH wb_incandescent